Maastricht IBS Cohort
To set up a cohort of at least 400 IBS patients in order to identify different patient subgroups according to phenotypical and genotypical patterns and
To set up a biobank for future translational studies on the pathophysiology of IBS, in order to identify genetic factors to unravel the pathogenesis of IBS and to provide novel therapeutic targets.
Irritable Bowel Syndrome
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Maastricht IBS Cohort: Phenotypical and Genotypical Characterization of Patients With Irritable Bowel Syndrome.|
|Study Start Date:||September 2009|
|Estimated Study Completion Date:||September 2024|
|Estimated Primary Completion Date:||September 2024 (Final data collection date for primary outcome measure)|
Aim of the present study is to set up a large cohort of IBS patients in order to identify different disease characteristics as well as aetiological and pathophysiological factors in (sub)groups of patients with this heterogeneous disorder. Various phenotypical and genotypical markers will be evaluated. For this purpose, blood and faecal samples as well as symptom questionnaires will be collected and visceral perception and intestinal permeability will be measured. In order to increase the sensitivity of the barostat procedure, a pilot study will be performed by measuring patients and healthy controls under meal stimulated and fasting conditions. We aim to set up a biobank for studies on the pathophysiology of IBS, in order to identify genetic factors that may help unravel the pathogenesis of IBS and provide novel therapeutic targets. Consent will be asked to collect data from questionnaires, to store serum samples, DNA, stool and, when endoscopy is performed for clinical reasons, also biopsy specimens.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00775060
|Contact: José M Conchillo, MD, PhD||+31 43 email@example.com|
|Contact: José M Conchillo, MD PhD firstname.lastname@example.org|
|Principal Investigator: José M Conchillo, MD PhD|
|Study Director:||Ad Masclee, MD PhD||Maastricht University Medical Center|